The Schall Law Firm Is Looking Into Whether Sage Therapeutics Inc. Violated Securities Regulations And Investors Are Urged To Reach OutAccesswire • 09/01/24
SAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • 09/01/24
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGEGlobeNewsWire • 09/01/24
Stakeholders In Sage Therapeutics Inc Are Invited To Participate With The Schall Law Firm In An Investigation Into Possible Securities FraudAccesswire • 08/31/24
SAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sage Therapeutics, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 08/31/24
Sage Therapeutics Inc Is Being Sued For Securities Law Infractions And Stakeholders With Losses Should Contact The Schall Law FirmAccesswire • 08/30/24
SAGE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 08/30/24
SAGE THERAPEUTICS, INC. (NASDAQ: SAGE) INVESTOR ALERT: Investors With Large Losses in Sage Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsGlobeNewsWire • 08/30/24
Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Sage Therapeutics, Inc.GlobeNewsWire • 08/29/24
SAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Sage Therapeutics Class Action LawsuitGlobeNewsWire • 08/29/24
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Sage Therapeutics, Inc. (SAGE) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmGlobeNewsWire • 08/29/24
Sage Therapeutics Inc. Is Being Inquired Into For Securities Impropriety And The Schall Law Firm Wants Impacted Investors To Reach OutAccesswire • 08/29/24
Pomerantz Law Firm Announces the Filing of a Class Action Against Sage Therapeutics, Inc. and Certain Officers – SAGEAccesswire • 08/29/24
Shareholders With Losses In Sage Therapeutics Inc Are Invited To Contact The Schall Law Firm About An Investigation Into Potential Securities FraudAccesswire • 08/28/24
The Schall Law Firm Is Looking Into Possible Securities Infractions By Sage Therapeutics Inc And Investors Are Urged To ParticipateAccesswire • 08/27/24
An Inquiry Has Been Launched Into Sage Therapeutics Inc For Securities Fraud And The Schall Law Firm Invites Impacted Shareholders To HelpAccesswire • 08/26/24
The Schall Law Firm Is Seeking Investors In Sage Therapeutics Inc To Join An Investigation Into Possible Securities Law ViolationsAccesswire • 08/25/24
The Schall Law Firm Is Inquiring Into Sage Therapeutics Inc For Securities Fraud And Stockholders Are Invited To Play A PartAccesswire • 08/24/24
Sage Therapeutics Inc Is Being Looked Into By The Schall Law Firm For Securities Law Violations And Investors Are Asked To JoinAccesswire • 08/23/24
An Investigation Into Sage Therapeutics Inc For Possible Securities Fraud Has Been Opened By The Schall Law Firm And Affected Shareholders Are Urged To ParticipateAccesswire • 08/22/24
The Schall Law Firm Is Looking Into Sage Therapeutics Inc.'s Potential Securities Law Violations And Urges Investors To HelpAccesswire • 08/21/24
The Schall Law Firm Is Investigating Sage Therapeutics Inc. For Possible Securities Law Violations And Seeks Shareholders To ParticipateAccesswire • 08/20/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGEAccesswire • 08/19/24
The Schall Law Firm Is Inquiring Into Possible Securities Law Violations By Sage Therapeutics Inc. And Wants Investors To HelpAccesswire • 08/19/24
The Schall Law Firm Is Investigating Sage Therapeutics Inc. For Securities Violations And Wants Shareholders To HelpAccesswire • 08/18/24
